[Clinical trial in acute and subacute inflammations of aspecific etiology involving the pelvis, with a new synthetic product: "tantum biotic"].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy*; D006801:Humans; D010249:Parametritis / Q000188:drug therapy; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy; D011720:Pyrazoles / Q000627:therapeutic use*; D012488:Salpingitis / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D011720:Pyrazoles
Sperimentazione clinica nelle flogosi acute e subacute ad etiologia aspecifica interessantil la pelvi, con un nuovo prodotto di sintesi: "tantum biotic".